New York - London - Athens - Oslo

Tekla Life Sciences Investors (NYSE:HQL)

Stock data as of Tue. Aug. 22, 2017 9:59 AM
Last Trade

20.69

Change

0.17 (0.80%)

Volume

10079

Open: 20.56
Daily Low: 20.56
Daily High: 20.70
Fund Data Provided by Morningstar
Net Assets($,000s): 519,350
Market Cap($,000s): 519,157
Discount: -0.04%
1Mo. Total Market Return: -4.00%
6Mo. Total Market Return: 26.70%
YTD Total Market Return: 10.00
1Mo. Total NAV Return: -0.60%
6Mo. Total NAV Return: 20.00%
YTD Total NAV Return: 8.80
1Mo. Peer Group Return: -1.10%
6Mo.Peer Group Return: 20.60%
YTD Peer Group Return: 7.70



More information is available at http://www.hqcm.com/hql_reports_news.aspx

Recent News

Tekla Life Sciences Investors (HQL) on Focus After Forming Bullish Double Top ...

2017-11-13 08:46:07  -  KL Daily - Nov 13, 2017 Investors sentiment increased to 1.5 in Q2 2017. Its up 0.77, from 0.73 in 2017Q1. It increased, as 4 investors sold Tekla Life Sciences Investors shares while 10 reduced holdings. 6 funds opened positions while 15 raised stakes. 2.14 million shares or ...

Could Tekla Life Sciences Investors (HQL) Change Direction After This Bullish ...

2017-11-13 08:41:15  -  BZ Weekly - Nov 13, 2017 Investors sentiment increased to 1.5 in 2017 Q2. Its up 0.77, from 0.73 in 2017Q1. It increased, as 4 investors sold Tekla Life Sciences Investors shares while 10 reduced holdings. 6 funds opened positions while 15 raised stakes. 2.14 million shares or ...

Tekla Life Sciences Investors (HQL) Forms $19.75 Double Top; Allstate Has ...

2017-11-13 07:11:15  -  Wolcott Daily - Nov 13, 2017 Tekla Life Sciences Investors (HQL) formed double top with $20.34 target or 3.00% above today's $19.75 share price. Tekla Life Sciences Investors (HQL) has $418.11M valuation. The stock decreased 0.20% or $0.04 on November 10, reaching $19.75.

Citigroup Reconfirms a Neutral Rating on Boston Beer Co (SAM) and $181 Target ...

2017-11-01 10:26:15  -  Key Gazette - 2 hours ago Among 14 analysts covering Boston Beer Co (NYSE:SAM), 2 have Buy rating, 5 Sell and 7 Hold. Therefore 14% are positive. Boston Beer Co has $295 highest and $126.0 lowest target. Market Focus: Minus Directional Indicator Noted Above Plus Directional ... - Danville Daily


Tekla Life Sciences Investors (HQL) Stock Formed Bullish Double Top Pattern ...

2017-10-28 12:30:00  -  BZ Weekly - Oct 28, 2017 Investors sentiment increased to 1.5 in 2017 Q2. Its up 0.77, from 0.73 in 2017Q1. It is positive, as 4 investors sold Tekla Life Sciences Investors shares while 10 reduced holdings. 6 funds opened positions while 15 raised stakes. 2.14 million shares ...

The 7% $100000 CEF Portfolio For The Retiree: 12 CEFs Along With A Suggested ...

2016-07-27 05:33:45  -  Seeking Alpha - 3 hours ago This is the 14th article in the series of putting together a 7% CEF portfolio that also protects against capital loss. Twelve CEFs have been back-tested 5 years that offer the retiree 7% cash returns and capital maintenance.

CardioKinetix Announces the 500th Parachute Heart Failure Device Implantation

2016-07-21 08:00:00  -  Business Wire (press release) - 7 hours ago Privately held, the company is backed by U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, Lexington Private Equity, and Edwards ...

H&Q Life Sciences Investors (NYSE:HQL) Institutional Investors Quarterly Sentiment

2016-07-12 18:41:15  -  Consumer Eagle - 17 hours ago Tekla Life Sciences Investors, formerly H&Q Life Sciences Investors, is a diversified closed-end management investment fund.

Large Inflow of Money Witnessed in Tekla Healthcare Investors

2016-06-30 06:30:00  -  Market Digest - Jun 30, 2016 Tekla Healthcare Investors (NYSE:HQH) : $1.59 million worth of transactions were on upticks in Tekla Healthcare Investors (NYSE:HQH), compared to $1.21 million on downticks. The ratio between the two was 1.31, whereas, the net money flow stood at a ...

Tekla Life Sciences Investors (HQL) Ex-Dividend Date Scheduled for June 21, 2016

2016-06-20 09:07:30  -  Nasdaq - 8 hours ago Tekla Life Sciences Investors ( HQL ) will begin trading ex-dividend on June 21, 2016. A cash dividend payment of $0.82 per share is scheduled to be paid on August 12, 2016.

» View all news